Bicycle Therapeutics (BCYC) Interest Coverage Ratio (2018 - 2026)
Bicycle Therapeutics (BCYC) posted Interest Coverage Ratio of 18.22 for Q1 2026, up 95.8% on a QoQ basis from 433.47 in Q4 2025, and up 13.84% year-over-year from 16.01 in Q1 2025.
Bicycle Therapeutics (BCYC) Interest Coverage Ratio (2018 - 2026) Analysis & Trends
Bicycle Therapeutics' Interest Coverage Ratio history runs 9 years deep, the most recent figure standing at 18.22 for Q1 2026.
- Quarterly Interest Coverage Ratio rose 13.84% year-over-year to 18.22 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 67.45 (up 9.86% YoY) and the FY2025 annual result came in at 1.95, up 7.44% from the prior year.
- Interest Coverage Ratio was 18.22 for Q1 2026 at Bicycle Therapeutics, up from 433.47 in the prior quarter.
- Across five years, Interest Coverage Ratio topped out at 0.52 in Q1 2024 and bottomed at 433.47 in Q4 2025.
- A 5-year average of 53.95 and a median of 18.22 in 2026 frame the typical range for Interest Coverage Ratio.
- Annual changes were most pronounced in 2023 — Interest Coverage Ratio jumped 96.42% — and 2025, when it sank 4005.45%.
- Bicycle Therapeutics' Interest Coverage Ratio stood at 117.13 in 2022, then slumped by 49.36% to 174.95 in 2023, then soared by 68.35% to 55.37 in 2024, then slumped by 682.86% to 433.47 in 2025, then jumped by 95.8% to 18.22 in 2026.
- Business Quant data shows BCYC's Interest Coverage Ratio at 18.22 in Q1 2026, 433.47 in Q4 2025, and 21.3 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | Bicycle Therapeutics | 289.88 Mn | 289.88 Mn | - | -18.22 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -18.22 |
| Dec 31, 2025 | -433.47 |
| Sep 30, 2025 | -21.30 |
| Jun 30, 2025 | -32.61 |
| Mar 31, 2025 | -21.15 |
| Dec 31, 2024 | -55.37 |
| Sep 30, 2024 | -1.47 |
| Jun 30, 2024 | -1.52 |
| Mar 31, 2024 | -0.52 |
| Dec 31, 2023 | -174.95 |
| Sep 30, 2023 | -1.71 |
| Jun 30, 2023 | -0.81 |
| Mar 31, 2023 | -1.20 |
| Dec 31, 2022 | -117.13 |
| Sep 30, 2022 | -0.68 |
| Jun 30, 2022 | -1.47 |
| Mar 31, 2022 | -33.48 |
| Dec 31, 2021 | -21.98 |
| Sep 30, 2021 | -0.11 |
| Jun 30, 2021 | -0.22 |